Structural Heart Closure Devices | Market Insights | Asia Pacific (Supplemental) | 2023
The global COVID-19 pandemic negatively impacted the Asia Pacific structural heart closure device market to some extent. Given most structural heart closure procedures, including congenital heart defect closure, PFO closure, and LAA closure, are considered nonurgent, COVID-19 response measures resulted in strong declines in structural heart closure procedure volumes in early 2020, although strong prepandemic growth trends in the PFO and LAA segments helped to sustain positive overall procedure volume and market growth for the year. In 2021, procedure volume and market growth increased strongly as deferred procedures were performed, and going forward the market will continue to expand through 2031, fueled by strong expansion of the PFO and LAA closure device spaces.
This Medtech 360 Report provides comprehensive data and analysis on the state of the structural heart closure device market in Asia Pacific from 2019 through 2031.
